Inari Medical Inc (NARI)
Interest coverage
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 4,442 | 2,813 | -12,059 | -23,989 | -25,891 | -19,401 | -12,832 | 184 | 10,980 | 16,284 | 25,701 | 18,206 |
Interest expense (ttm) | US$ in thousands | 196 | 201 | 232 | 261 | 294 | 295 | 294 | 295 | 295 | 295 | 473 | 862 |
Interest coverage | 22.66 | 14.00 | -51.98 | -91.91 | -88.06 | -65.77 | -43.65 | 0.62 | 37.22 | 55.20 | 54.34 | 21.12 |
December 31, 2023 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $4,442K ÷ $196K
= 22.66
The interest coverage ratio for Inari Medical Inc in Q1 2022 was 0.31, indicating that the company's operating income was only able to cover 31% of its interest expense for that period. Unfortunately, without data for the subsequent quarters of 2023, it is not possible to provide a detailed analysis of the trend in interest coverage and assess the company's ability to meet its interest obligations in recent quarters.
Peer comparison
Dec 31, 2023
Company name
Symbol
Interest coverage
Inari Medical Inc
NARI
22.66
3M Company
MMM
-9.28
Artivion Inc
AORT
0.15
Baxter International Inc
BAX
6.14
Becton Dickinson and Company
BDX
4.24
Boston Scientific Corp
BSX
8.81
DexCom Inc
DXCM
36.00
Embecta Corp
EMBC
20.25
Glaukos Corp
GKOS
-8.81
Globus Medical
GMED
8.96
Haemonetics Corporation
HAE
8.46